Pfizer Plans to Sell Covid Shot for $110

“Pfizer gave some details about its plans to sell the Covid-19 vaccine it developed with BioNTech on the commercial market in the U.S., saying it expects to price the shot at $110 to $130 per dose for adults,” the Wall Street Journal reports.

The U.S. government paid $19.50 a dose for the Pfizer vaccine under its first contract, and $30.50 under its most recent one.